Robert J. Amato

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

Claude Sportès, Frances T. Hakim, Sarfraz Memon et al. · The Journal of Experimental Medicine · 2008 · 467 citations · Full text

Life Sciences, Immunology, Clinical Immunology +16

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial

Shi‐Ming Tu, Randall E. Millikan, Bayabel Mengistu et al. · The Lancet · 2001 · 395 citations

Medicine, Oncology, Urology +16

A Molecular Classification of Papillary Renal Cell Carcinoma

Ximing J. Yang, Min-Han Tan, Hyung L. Kim et al. · Cancer Research · 2005 · 234 citations · Full text

Medicine, Molecular Biology, Oncology +17

Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy

Claude Sportès, Rebecca Babb, Michael Krumlauf et al. · Clinical Cancer Research · 2010 · 222 citations · Full text

Life Sciences, Immunology, Pharmacology +17